# A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms

> **NCT00646048** · PHASE1 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 43 (actual)

## Conditions studied

- Abdominal Aortic Aneurysm

## Interventions

- **DEVICE:** TriVascular Stent-Graft System

## Key facts

- **NCT ID:** NCT00646048
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2004-11
- **Final completion:** 2010-03
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2011-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646048, "A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00646048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*